BANK VONTOBEL/CALL/CVS HEALTH/68/0.1/21.06.24 Share Price

Warrant

DE000VM1C2K7

Delayed Deutsche Boerse AG 02:08:01 17/06/2024 pm IST
0.003 EUR -25.00% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/68/0.1/21.06.24
Current month-50.00%
1 month-33.33%
Date Price Change
17/24/17 0.003 -25.00%
14/24/14 0.004 +100.00%
13/24/13 0.002 0.00%
12/24/12 0.002 -50.00%
11/24/11 0.004 -20.00%

Delayed Quote Deutsche Boerse AG

Last update June 17, 2024 at 02:08 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM1C2K
ISINDE000VM1C2K7
Date issued 18/08/2023
Strike 68 $
Maturity 21/06/2024 (5 Days)
Parity 10 : 1
Emission price 0.63
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.5
Lowest since issue 0.002
Spread 0.017
Spread %85.00%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
60.22 USD
Average target price
69.02 USD
Spread / Average Target
+14.61%
Consensus